Global DNA Diagnostics & Testing Market Growth (Status and Outlook) 2024-2030

2024

Global DNA Diagnostics & Testing Market Growth (Status and Outlook) 2024-2030

Name: Global DNA Diagnostics & Testing Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001366
Price: 3450 USD
Availability: InStock
Rating: 5 (15.95 reviews)

The global DNA diagnostics and testing market is valued at US$ 10.04 billion in 2024 and is expected to slightly decrease to US$ 9.89 billion by 2030, reflecting a slight dip in gr

Bonafide Trust
11-09-2024
Pages : 117
Figures : 79
Tables : 117
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global DNA Diagnostics & Testing market was valued at US$ 10,040 million in 2024 and is forecast to reach US$ 9,892 million by 2030, reflecting a slight decrease with a CAGR of -0.2% during the forecast period. This decline suggests that while the market will continue to see demand in the downstream market, growth may be slower than anticipated. However, the market still holds substantial growth potential, primarily driven by technological advancements, increasing demand for accurate diagnostics, and expanding applications in various healthcare and forensic fields. DNA diagnostics and testing are crucial for the diagnosis of genetic disorders, identification of infectious diseases, and cancer detection. As personalized medicine and targeted therapies gain traction, DNA diagnostics is becoming a critical tool for clinicians to develop customized treatment plans for patients. Moreover, advancements in DNA sequencing technologies such as Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) have revolutionized the ability to diagnose genetic abnormalities and infections more precisely and rapidly. In addition to the healthcare applications, the use of DNA diagnostics and testing in forensics and identity verification has been expanding. However, the market faces challenges such as high upfront costs, the complexity of procedures, and the need for advanced infrastructure to conduct tests. As the market matures, key players in the DNA diagnostics industry need to focus on reducing costs, improving the efficiency of diagnostics, and overcoming regulatory challenges to ensure the widespread adoption of these technologies. Additionally, competition is increasing with new entrants emerging and established companies enhancing their technological offerings, thus requiring market players to invest in research and development to maintain their competitive edge and meet the evolving needs of consumers.

The pharmaceutical market, valued at US$ 1,475 billion in 2022, is expected to grow at a CAGR of 5% over the next six years. This growth is driven by several factors, including technological advancements, an increasing demand for healthcare, a rising prevalence of chronic diseases, and an increased focus on pharmaceutical R&D. In 2022, the biologics segment of the pharmaceutical market was valued at US$ 381 billion, showing strong growth prospects compared to the chemical drug market, which increased from US$ 1,005 billion in 2018 to US$ 1,094 billion in 2022. As the demand for advanced therapies rises, the pharmaceutical industry is increasingly focused on biologics and other cutting-edge treatment modalities. However, the industry is facing several challenges, including stringent regulations, high R&D costs, and the expiration of patents for blockbuster drugs, which is impacting revenue generation for established companies. To address these challenges, pharmaceutical companies must continuously innovate and adapt to emerging trends such as gene therapies, precision medicine, and the growing use of DNA diagnostics and testing. The COVID-19 pandemic has underscored the importance of robust vaccine development and effective supply chain management, which has accelerated investment in pharmaceutical R&D. Furthermore, government funding and private investments in the development of new drugs and therapies have increased, which is helping drive the growth of the pharmaceutical sector. As global healthcare needs evolve and the prevalence of chronic diseases continues to rise, pharmaceutical companies must adapt to meet these demands while staying competitive in a rapidly changing landscape. The growing integration of genetic testing, such as DNA diagnostics, in the drug development process further emphasizes the growing significance of DNA testing in personalized medicine and precision healthcare.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The research report on the DNA Diagnostics & Testing market offers a comprehensive analysis of various aspects that influence the industry. It includes insights into market size and growth trends, segmentation by type and application, and a breakdown of regional markets. The report details key market drivers such as government regulations, technological advancements, and the increasing demand for personalized medicine. It also identifies the challenges faced by the industry, including infrastructure limitations, high testing costs, and regulatory hurdles. The growth potential of the market is evident, as advancements in DNA testing technologies and the increasing emphasis on healthcare personalization continue to drive demand. However, the market is also influenced by certain constraints that need to be addressed to fully capitalize on its growth potential. Cost-effective testing solutions, streamlined supply chains, and the development of more affordable and accessible DNA diagnostic services are crucial for the widespread adoption of these technologies. Additionally, the report highlights the competitive landscape, providing profiles of key players in the market, their strategies, market share, and product offerings. As new entrants emerge and established companies enhance their technological capabilities, the market is becoming increasingly competitive, making innovation and strategic partnerships vital for success. Market players are encouraged to invest in research and development to stay ahead of the competition and respond to changing consumer preferences. By focusing on product differentiation and optimizing the efficiency of DNA testing technologies, market participants can position themselves to capture growth opportunities in this evolving field.

Technological advancements are at the core of the evolution of the DNA Diagnostics & Testing industry. Innovations such as Next-Generation Sequencing (NGS), PCR-based diagnostics, and in-situ hybridization diagnostics are significantly enhancing the accuracy and efficiency of genetic testing. These technologies are not only improving the detection of genetic disorders and infections but also enabling the development of personalized treatments tailored to the specific genetic makeup of patients. NGS, in particular, has revolutionized genomics, allowing for faster, more cost-effective sequencing of entire genomes. This technology is expected to further advance as the demand for personalized medicine increases, helping to drive the growth of the DNA diagnostics market. In addition to advancements in diagnostic technologies, the market is also witnessing the emergence of new players and investment in cutting-edge research. These new entrants bring fresh perspectives and innovative solutions that may disrupt existing market dynamics. The report emphasizes that companies need to stay ahead of technological trends, exploring new diagnostic approaches and leveraging emerging technologies to meet the evolving needs of healthcare providers and patients. The continued investment in R&D and the exploration of novel approaches to DNA testing will play a crucial role in shaping the future of this market. Additionally, the rise of AI and machine learning in data analysis is expected to further enhance the capabilities of DNA diagnostics, providing more accurate and timely results while reducing human error and processing times.

The DNA Diagnostics & Testing market is segmented by type into PCR-based diagnostics, NGS DNA diagnosis, in-situ hybridization diagnostics, and micro-arrays-based diagnostics. Each type serves different applications and offers unique benefits. PCR-based diagnostics are widely used for detecting genetic mutations, bacterial and viral infections, and other diseases. NGS DNA diagnosis has emerged as a powerful tool in genomics, enabling researchers and clinicians to sequence entire genomes and analyze genetic variations in a more detailed manner. This technology is particularly useful in personalized medicine, cancer diagnostics, and rare disease detection. In-situ hybridization diagnostics, which involve the use of labeled probes to detect specific nucleic acid sequences, are crucial in identifying specific genetic abnormalities and abnormalities in cells or tissues. This technique is widely used in oncology and pathology for diagnosing genetic disorders. Micro-arrays-based diagnostics are used to analyze gene expression patterns and detect various genetic mutations. This technology is particularly useful in research and clinical diagnostics for profiling genes involved in diseases such as cancer. The market is also segmented by application, with key areas including oncology diagnostics and histopathology, identity diagnostics and forensics, and pharmacogenomics diagnostic testing and drug metabolism. In oncology, DNA testing is used to identify genetic mutations and molecular markers that help guide cancer treatment decisions. In identity diagnostics and forensics, DNA testing plays a critical role in identification and forensic investigations, aiding law enforcement and legal proceedings. Pharmacogenomics diagnostic testing helps in assessing how genetic variations affect drug responses, facilitating the development of personalized drug therapies and improving drug efficacy. These applications highlight the growing importance of DNA diagnostics in various sectors, with advancements in technology continuing to drive the market's growth and expanding its reach.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DNA Diagnostics & Testing Market Size 2019-2030
2.1.2 DNA Diagnostics & Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 DNA Diagnostics & Testing Segment by Type
2.2.1 PCR Based Diagnostics
2.2.2 NGS DNA Diagnosis
2.2.3 In-situ Hybridization Diagnostics
2.2.4 Micro-arrays Based Diagnostics
2.3 DNA Diagnostics & Testing Market Size by Type
2.3.1 DNA Diagnostics & Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
2.4 DNA Diagnostics & Testing Segment by Application
2.4.1 Oncology Diagnostics & Histopathology
2.4.2 Identity Diagnostics & Forensics
2.4.3 Pharmacogenomics Diagnostic Testing & Drug Metabolism
2.5 DNA Diagnostics & Testing Market Size by Application
2.5.1 DNA Diagnostics & Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
3 DNA Diagnostics & Testing Market Size by Player
3.1 DNA Diagnostics & Testing Market Size Market Share by Players
3.1.1 Global DNA Diagnostics & Testing Revenue by Players (2019-2024)
3.1.2 Global DNA Diagnostics & Testing Revenue Market Share by Players (2019-2024)
3.2 Global DNA Diagnostics & Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DNA Diagnostics & Testing by Regions
4.1 DNA Diagnostics & Testing Market Size by Regions (2019-2024)
4.2 Americas DNA Diagnostics & Testing Market Size Growth (2019-2024)
4.3 APAC DNA Diagnostics & Testing Market Size Growth (2019-2024)
4.4 Europe DNA Diagnostics & Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa DNA Diagnostics & Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas DNA Diagnostics & Testing Market Size by Country (2019-2024)
5.2 Americas DNA Diagnostics & Testing Market Size by Type (2019-2024)
5.3 Americas DNA Diagnostics & Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA Diagnostics & Testing Market Size by Region (2019-2024)
6.2 APAC DNA Diagnostics & Testing Market Size by Type (2019-2024)
6.3 APAC DNA Diagnostics & Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe DNA Diagnostics & Testing by Country (2019-2024)
7.2 Europe DNA Diagnostics & Testing Market Size by Type (2019-2024)
7.3 Europe DNA Diagnostics & Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa DNA Diagnostics & Testing by Region (2019-2024)
8.2 Middle East & Africa DNA Diagnostics & Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa DNA Diagnostics & Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global DNA Diagnostics & Testing Market Forecast
10.1 Global DNA Diagnostics & Testing Forecast by Regions (2025-2030)
10.1.1 Global DNA Diagnostics & Testing Forecast by Regions (2025-2030)
10.1.2 Americas DNA Diagnostics & Testing Forecast
10.1.3 APAC DNA Diagnostics & Testing Forecast
10.1.4 Europe DNA Diagnostics & Testing Forecast
10.1.5 Middle East & Africa DNA Diagnostics & Testing Forecast
10.2 Americas DNA Diagnostics & Testing Forecast by Country (2025-2030)
10.2.1 United States DNA Diagnostics & Testing Market Forecast
10.2.2 Canada DNA Diagnostics & Testing Market Forecast
10.2.3 Mexico DNA Diagnostics & Testing Market Forecast
10.2.4 Brazil DNA Diagnostics & Testing Market Forecast
10.3 APAC DNA Diagnostics & Testing Forecast by Region (2025-2030)
10.3.1 China DNA Diagnostics & Testing Market Forecast
10.3.2 Japan DNA Diagnostics & Testing Market Forecast
10.3.3 Korea DNA Diagnostics & Testing Market Forecast
10.3.4 Southeast Asia DNA Diagnostics & Testing Market Forecast
10.3.5 India DNA Diagnostics & Testing Market Forecast
10.3.6 Australia DNA Diagnostics & Testing Market Forecast
10.4 Europe DNA Diagnostics & Testing Forecast by Country (2025-2030)
10.4.1 Germany DNA Diagnostics & Testing Market Forecast
10.4.2 France DNA Diagnostics & Testing Market Forecast
10.4.3 UK DNA Diagnostics & Testing Market Forecast
10.4.4 Italy DNA Diagnostics & Testing Market Forecast
10.4.5 Russia DNA Diagnostics & Testing Market Forecast
10.5 Middle East & Africa DNA Diagnostics & Testing Forecast by Region (2025-2030)
10.5.1 Egypt DNA Diagnostics & Testing Market Forecast
10.5.2 South Africa DNA Diagnostics & Testing Market Forecast
10.5.3 Israel DNA Diagnostics & Testing Market Forecast
10.5.4 Turkey DNA Diagnostics & Testing Market Forecast
10.5.5 GCC Countries DNA Diagnostics & Testing Market Forecast
10.6 Global DNA Diagnostics & Testing Forecast by Type (2025-2030)
10.7 Global DNA Diagnostics & Testing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories DNA Diagnostics & Testing Product Offered
11.1.3 Abbott Laboratories DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Affymetrix Inc.
11.2.1 Affymetrix Inc. Company Information
11.2.2 Affymetrix Inc. DNA Diagnostics & Testing Product Offered
11.2.3 Affymetrix Inc. DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Affymetrix Inc. Main Business Overview
11.2.5 Affymetrix Inc. Latest Developments
11.3 Agilent Technologies Inc
11.3.1 Agilent Technologies Inc Company Information
11.3.2 Agilent Technologies Inc DNA Diagnostics & Testing Product Offered
11.3.3 Agilent Technologies Inc DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Inc Main Business Overview
11.3.5 Agilent Technologies Inc Latest Developments
11.4 Applied Biosystems Group
11.4.1 Applied Biosystems Group Company Information
11.4.2 Applied Biosystems Group DNA Diagnostics & Testing Product Offered
11.4.3 Applied Biosystems Group DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Applied Biosystems Group Main Business Overview
11.4.5 Applied Biosystems Group Latest Developments
11.5 Illumina Inc.
11.5.1 Illumina Inc. Company Information
11.5.2 Illumina Inc. DNA Diagnostics & Testing Product Offered
11.5.3 Illumina Inc. DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Illumina Inc. Main Business Overview
11.5.5 Illumina Inc. Latest Developments
11.6 Cepheid Inc.
11.6.1 Cepheid Inc. Company Information
11.6.2 Cepheid Inc. DNA Diagnostics & Testing Product Offered
11.6.3 Cepheid Inc. DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Cepheid Inc. Main Business Overview
11.6.5 Cepheid Inc. Latest Developments
11.7 Hologic
11.7.1 Hologic Company Information
11.7.2 Hologic DNA Diagnostics & Testing Product Offered
11.7.3 Hologic DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hologic Main Business Overview
11.7.5 Hologic Latest Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Information
11.8.2 Bio-Rad Laboratories DNA Diagnostics & Testing Product Offered
11.8.3 Bio-Rad Laboratories DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bio-Rad Laboratories Main Business Overview
11.8.5 Bio-Rad Laboratories Latest Developments
11.9 Dako
11.9.1 Dako Company Information
11.9.2 Dako DNA Diagnostics & Testing Product Offered
11.9.3 Dako DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Dako Main Business Overview
11.9.5 Dako Latest Developments
11.10 Abbott
11.10.1 Abbott Company Information
11.10.2 Abbott DNA Diagnostics & Testing Product Offered
11.10.3 Abbott DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Abbott Main Business Overview
11.10.5 Abbott Latest Developments
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Information
11.11.2 Roche Diagnostics DNA Diagnostics & Testing Product Offered
11.11.3 Roche Diagnostics DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Roche Diagnostics Main Business Overview
11.11.5 Roche Diagnostics Latest Developments
11.12 Beckman Coulter Inc.
11.12.1 Beckman Coulter Inc. Company Information
11.12.2 Beckman Coulter Inc. DNA Diagnostics & Testing Product Offered
11.12.3 Beckman Coulter Inc. DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Beckman Coulter Inc. Main Business Overview
11.12.5 Beckman Coulter Inc. Latest Developments
11.13 Siemens Healthcare
11.13.1 Siemens Healthcare Company Information
11.13.2 Siemens Healthcare DNA Diagnostics & Testing Product Offered
11.13.3 Siemens Healthcare DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Siemens Healthcare Main Business Overview
11.13.5 Siemens Healthcare Latest Developments
12 Research Findings and Conclusion

Table 1. DNA Diagnostics & Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of PCR Based Diagnostics
Table 3. Major Players of NGS DNA Diagnosis
Table 4. Major Players of In-situ Hybridization Diagnostics
Table 5. Major Players of Micro-arrays Based Diagnostics
Table 6. DNA Diagnostics & Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global DNA Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 9. DNA Diagnostics & Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global DNA Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 12. Global DNA Diagnostics & Testing Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global DNA Diagnostics & Testing Revenue Market Share by Player (2019-2024)
Table 14. DNA Diagnostics & Testing Key Players Head office and Products Offered
Table 15. DNA Diagnostics & Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global DNA Diagnostics & Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global DNA Diagnostics & Testing Market Size Market Share by Regions (2019-2024)
Table 20. Global DNA Diagnostics & Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global DNA Diagnostics & Testing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas DNA Diagnostics & Testing Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas DNA Diagnostics & Testing Market Size Market Share by Country (2019-2024)
Table 24. Americas DNA Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 26. Americas DNA Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 28. APAC DNA Diagnostics & Testing Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC DNA Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Table 30. APAC DNA Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 32. APAC DNA Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 34. Europe DNA Diagnostics & Testing Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe DNA Diagnostics & Testing Market Size Market Share by Country (2019-2024)
Table 36. Europe DNA Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 38. Europe DNA Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa DNA Diagnostics & Testing Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa DNA Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa DNA Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa DNA Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of DNA Diagnostics & Testing
Table 47. Key Market Challenges & Risks of DNA Diagnostics & Testing
Table 48. Key Industry Trends of DNA Diagnostics & Testing
Table 49. Global DNA Diagnostics & Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global DNA Diagnostics & Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global DNA Diagnostics & Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global DNA Diagnostics & Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 54. Abbott Laboratories DNA Diagnostics & Testing Product Offered
Table 55. Abbott Laboratories DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Affymetrix Inc. Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 59. Affymetrix Inc. DNA Diagnostics & Testing Product Offered
Table 60. Affymetrix Inc. Main Business
Table 61. Affymetrix Inc. DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Affymetrix Inc. Latest Developments
Table 63. Agilent Technologies Inc Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 64. Agilent Technologies Inc DNA Diagnostics & Testing Product Offered
Table 65. Agilent Technologies Inc Main Business
Table 66. Agilent Technologies Inc DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Agilent Technologies Inc Latest Developments
Table 68. Applied Biosystems Group Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 69. Applied Biosystems Group DNA Diagnostics & Testing Product Offered
Table 70. Applied Biosystems Group Main Business
Table 71. Applied Biosystems Group DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Applied Biosystems Group Latest Developments
Table 73. Illumina Inc. Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 74. Illumina Inc. DNA Diagnostics & Testing Product Offered
Table 75. Illumina Inc. Main Business
Table 76. Illumina Inc. DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Illumina Inc. Latest Developments
Table 78. Cepheid Inc. Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 79. Cepheid Inc. DNA Diagnostics & Testing Product Offered
Table 80. Cepheid Inc. Main Business
Table 81. Cepheid Inc. DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Cepheid Inc. Latest Developments
Table 83. Hologic Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 84. Hologic DNA Diagnostics & Testing Product Offered
Table 85. Hologic Main Business
Table 86. Hologic DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Hologic Latest Developments
Table 88. Bio-Rad Laboratories Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 89. Bio-Rad Laboratories DNA Diagnostics & Testing Product Offered
Table 90. Bio-Rad Laboratories Main Business
Table 91. Bio-Rad Laboratories DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Bio-Rad Laboratories Latest Developments
Table 93. Dako Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 94. Dako DNA Diagnostics & Testing Product Offered
Table 95. Dako Main Business
Table 96. Dako DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Dako Latest Developments
Table 98. Abbott Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 99. Abbott DNA Diagnostics & Testing Product Offered
Table 100. Abbott Main Business
Table 101. Abbott DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Abbott Latest Developments
Table 103. Roche Diagnostics Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 104. Roche Diagnostics DNA Diagnostics & Testing Product Offered
Table 105. Roche Diagnostics DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Roche Diagnostics Main Business
Table 107. Roche Diagnostics Latest Developments
Table 108. Beckman Coulter Inc. Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 109. Beckman Coulter Inc. DNA Diagnostics & Testing Product Offered
Table 110. Beckman Coulter Inc. Main Business
Table 111. Beckman Coulter Inc. DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Beckman Coulter Inc. Latest Developments
Table 113. Siemens Healthcare Details, Company Type, DNA Diagnostics & Testing Area Served and Its Competitors
Table 114. Siemens Healthcare DNA Diagnostics & Testing Product Offered
Table 115. Siemens Healthcare Main Business
Table 116. Siemens Healthcare DNA Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Siemens Healthcare Latest Developments
List of

Figure 1. DNA Diagnostics & Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global DNA Diagnostics & Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. DNA Diagnostics & Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. DNA Diagnostics & Testing Sales Market Share by Country/Region (2023)
Figure 8. DNA Diagnostics & Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global DNA Diagnostics & Testing Market Size Market Share by Type in 2023
Figure 10. DNA Diagnostics & Testing in Oncology Diagnostics & Histopathology
Figure 11. Global DNA Diagnostics & Testing Market: Oncology Diagnostics & Histopathology (2019-2024) & ($ Millions)
Figure 12. DNA Diagnostics & Testing in Identity Diagnostics & Forensics
Figure 13. Global DNA Diagnostics & Testing Market: Identity Diagnostics & Forensics (2019-2024) & ($ Millions)
Figure 14. DNA Diagnostics & Testing in Pharmacogenomics Diagnostic Testing & Drug Metabolism
Figure 15. Global DNA Diagnostics & Testing Market: Pharmacogenomics Diagnostic Testing & Drug Metabolism (2019-2024) & ($ Millions)
Figure 16. Global DNA Diagnostics & Testing Market Size Market Share by Application in 2023
Figure 17. Global DNA Diagnostics & Testing Revenue Market Share by Player in 2023
Figure 18. Global DNA Diagnostics & Testing Market Size Market Share by Regions (2019-2024)
Figure 19. Americas DNA Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 20. APAC DNA Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 21. Europe DNA Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa DNA Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 23. Americas DNA Diagnostics & Testing Value Market Share by Country in 2023
Figure 24. United States DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC DNA Diagnostics & Testing Market Size Market Share by Region in 2023
Figure 29. APAC DNA Diagnostics & Testing Market Size Market Share by Type in 2023
Figure 30. APAC DNA Diagnostics & Testing Market Size Market Share by Application in 2023
Figure 31. China DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. India DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe DNA Diagnostics & Testing Market Size Market Share by Country in 2023
Figure 38. Europe DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Figure 39. Europe DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Figure 40. Germany DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. France DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa DNA Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Figure 48. Egypt DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country DNA Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 54. APAC DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 55. Europe DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 57. United States DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 58. Canada DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 59. Mexico DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 60. Brazil DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 61. China DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 62. Japan DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 63. Korea DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 65. India DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 66. Australia DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 67. Germany DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 68. France DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 69. UK DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 70. Italy DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 71. Russia DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 72. Spain DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 73. Egypt DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 74. South Africa DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 75. Israel DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 76. Turkey DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries DNA Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 78. Global DNA Diagnostics & Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global DNA Diagnostics & Testing Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted